Opus Genetics, Inc. (IRD)

Profile

Full Name

Opus Genetics, Inc.

Ticker

NASDAQ: IRD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 19, 2015

Indexes

Not included

Website

https://opusgtx.com

Employees

18

Key Details

Price

$2.50(4.60%)

Market Cap

$172.41M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$10.99M(-42.30% YoY)

Annual EPS

-$2.15(-365.62% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.50
    IRD price is $2.50

    30-Day Relative Volume

    1.33
    IRD 30-day relative volume is 1.33

    Price Performance

    Price Most Recent Change

    +4.6%
    IRD price was up +4.6% on Dec 10, 2025

    Price YTD Change

    +110.08%
    IRD price is up +110.08% since January 1st

    Price 1-Year Change

    +108.33%
    IRD price is up +108.33% year-on-year

    Price 3-Year Change

    -18.83%
    IRD price is down -18.83% over the past 3 years

    Price Range

    Price All-Time High

    $4795.20
    IRD price is currently -99.95% below its historical high of $4795.20

    Price 3-Year Low

    $0.65
    IRD price is currently +284.62% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $172.41M
    IRD market cap is $172.41 million

    Market Cap 3-Year Change

    +169.03%
    IRD market cap is up +169.03% over the past 3 years

    Market Cap All-Time High

    $335.52M
    IRD market cap is currently -48.61% below its historical high of $335.52 million

    Market Cap Sector Percentile

    47.31%
    IRD market cap is higher than 47.31% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +118.46%
    IRD shares outstanding is up +118.46% year-on-year

    Shares Outstanding 3-Year Change

    +231.45%
    IRD shares outstanding is up +231.45% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.71
    IRD beta is 0.71

    200-day SMA

    $1.31
    IRD price is currently +90.55% above its 200-day simple moving average

    50-day SMA

    $2.02
    IRD price is currently +24.03% above its 50-day simple moving average

    14-Day RSI

    72.35
    IRD 14-day relative strength index is 72.35

    Volume

    1.33
    IRD 30-day relative volume is 1.33

    ATR

    $0.15
    IRD average true range is $0.15

    10-day Historical Volatility

    59.61%
    IRD 10-day historical volatility is 59.61%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $10.99M
    IRD annual revenue is $10.99 million

    Revenue Analysts Estimate

    $13.60M
    IRD annual revenue is currently -19.16% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -42.3%
    IRD annual revenue is down -42.3% year-on-year

    Revenue Sector Percentile

    49.46%
    IRD annual revenue is higher than 49.46% of companies in Healthcare sector

    EPS

    EPS

    -$2.15
    IRD annual earnings per share is -$2.15

    EPS Analysts Estimate

    -$0.63
    IRD annual earnings per share is currently -244.56% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -365.62%
    IRD annual earnings per share is down -365.62% year-on-year

    EPS Sector Percentile

    37.73%
    IRD annual earnings per share is higher than 37.73% of companies in Healthcare sector

    Profit

    Gross Profit

    $10.98M
    IRD annual gross profit is $10.98 million

    Gross Margin

    99.91%
    IRD annual gross profit margin is 99.91%

    Operating Profit

    -$34.07M
    IRD annual operating income is -$34.07 million

    Operating Margin

    -309.99%
    IRD annual operating profit margin is -309.99%

    Net Income

    -$57.53M
    IRD annual net profit is -$57.53 million

    Net Margin

    -523.40%
    IRD annual net profit margin is -523.40%

    Expenses

    Total Expenses

    $68.52M
    IRD annual total expenses is $68.52 million

    Operating Expenses

    $45.06M
    IRD annual total operating expenses is $45.06 million

    Cost Of Goods Sold

    $10.00K
    IRD annual cost of goods sold is $10.00 thousand

    Selling, General & Administrative Expenses

    $0.00
    IRD annual SG&A is $0.00

    Depreciation & Amortization

    $10.00K
    IRD annual D&A is $10.00 thousand

    Interest Expense

    $0.00
    IRD annual interest expense is $0.00

    Income Tax

    $0.00
    IRD annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$34.07M
    IRD annual earnings before interest & taxes is -$34.07 million

    EBITDA

    -$34.06M
    IRD annual EBITDA is -$34.06 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $36.89M
    IRD annual total assets is $36.89 million

    Non Current Assets

    $252.00K
    IRD annual long term assets is $252.00 thousand

    Current Assets

    $36.61M
    IRD annual total current assets is $36.61 million

    Cash and Cash Equivalents

    $30.32M
    IRD annual cash & cash equivalents is $30.32 million

    Accounts Receivable

    $5.77M
    IRD annual accounts receivable is $5.77 million

    Inventory

    $0.00
    IRD annual inventory is $0.00

    Liabilities

    Total Liabilities

    $30.16M
    IRD annual total liabilities is $30.16 million

    Long Term Liabilities

    $27.00K
    IRD annual total long term liabilities is $27.00 thousand

    Current Liabilities

    $11.29M
    IRD annual current liabilities is $11.29 million

    Accounts Payable

    $3.15M
    IRD annual accounts payable is $3.15 million

    Debt

    Total Debt

    $18.84M
    IRD annual total debt is $18.84 million

    Total Debt 1-Year Change

    +100%
    IRD annual total debt is up +100% year-on-year

    Long Term Debt

    $18.84M
    IRD annual long term debt is $18.84 million

    Short Term Debt

    $0.00
    IRD annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    $6.72M
    IRD annual stockholders equity is $6.72 million

    Book Value

    $6.72M
    IRD annual book value is $6.72 million

    Retained Earnings

    -$139.00M
    IRD annual retained earnings is -$139.00 million

    Working Capital

    $25.32M
    IRD annual working capital is $25.32 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$25.58M
    IRD annual cash from operations is -$25.58 million

    Cash From Operations 1-Year Change

    -2200%
    IRD annual cash from operations is down -2200% year-on-year

    Cash From Investing

    $1.21M
    IRD annual cash from investing is $1.21 million

    Cash From Investing 1-Year Change

    +100%
    IRD annual cash from investing is up +100% year-on-year

    Cash From Financing

    $4.19M
    IRD annual cash from financing is $4.19 million

    Cash From Financing 1-Year Change

    -53.38%
    IRD annual cash from financing is down -53.38% year-on-year

    CAPEX

    CAPEX

    $0.00
    IRD annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    IRD annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$25.58M
    IRD annual free cash flow is -$25.58 million

    Free Cash Flow 1-Year Change

    -2200%
    IRD annual free cash flow is down -2200% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    99.91%
    IRD annual gross profit margin is 99.91%

    Operating Margin

    -309.99%
    IRD annual operating profit margin is -309.99%

    Net Margin

    -523.40%
    IRD annual net profit margin is -523.40%

    ROA & ROE

    ROA

    -126.67%
    IRD annual return on assets is -126.67%

    ROE

    -203.19%
    IRD annual return on equity is -203.19%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    IRD price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    IRD price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    28.89
    IRD price to book ratio is 28.89

    PB Ratio Sector Percentile

    95.17%
    IRD price to book ratio is higher than 95.17% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    11.78
    IRD price to sales ratio is 11.78

    PS Ratio Sector Percentile

    72.64%
    IRD price to sales ratio is higher than 72.64% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $142.66M
    IRD enterprise value is $142.66 million

    Enterprise Value Sector Percentile

    47.65%
    IRD enterprise value is higher than 47.65% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.84
    IRD EV/EBITDA is -3.84

    EV/EBITDA Sector Percentile

    29.45%
    IRD EV/EBITDA is higher than 29.45% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.24
    IRD annual current ratio is 3.24

    Quick Ratio

    3.24
    IRD annual quick ratio is 3.24

    Leverage

    Debt To Equity

    2.80
    IRD annual debt to equity ratio is 2.80

    Interest Coverage Ratio

    -
    IRD annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    IRD piotroski f-score is 3

    Altman Z-Score

    -3.77
    IRD altman z-score is -3.77

    Analyst ratings

    Recent major analysts updates

    Nov 25, 25 Piper Sandler
    Overweight
    Nov 13, 25 Chardan Capital
    Buy
    Nov 7, 25 Chardan Capital
    Buy
    Oct 29, 25 Wedbush
    Outperform
    Oct 16, 25 Chardan Capital
    Buy
    Jun 27, 25 HC Wainwright & Co.
    Buy
    Jun 17, 25 LUCID CAPITAL MARKETS
    Buy
    Apr 11, 25 Craig-Hallum
    Buy
    Apr 1, 25 Jones Trading
    Buy
    Apr 1, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with IRD included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Opus Genetics, Inc.?
    • Does Opus Genetics, Inc. pay dividends?
    • What sector is Opus Genetics, Inc. in?
    • What industry is Opus Genetics, Inc. in?
    • What country is Opus Genetics, Inc. based in?
    • When did Opus Genetics, Inc. go public?
    • Is Opus Genetics, Inc. in the S&P 500?
    • Is Opus Genetics, Inc. in the NASDAQ 100?
    • Is Opus Genetics, Inc. in the Dow Jones?
    • When was Opus Genetics, Inc.'s last earnings report?
    • When does Opus Genetics, Inc. report earnings?

    What is the ticker symbol for Opus Genetics, Inc.?

    The ticker symbol for Opus Genetics, Inc. is NASDAQ:IRD

    Does Opus Genetics, Inc. pay dividends?

    No, Opus Genetics, Inc. does not pay dividends

    What sector is Opus Genetics, Inc. in?

    Opus Genetics, Inc. is in the Healthcare sector

    What industry is Opus Genetics, Inc. in?

    Opus Genetics, Inc. is in the Biotechnology industry

    What country is Opus Genetics, Inc. based in?

    Opus Genetics, Inc. is headquartered in United States

    When did Opus Genetics, Inc. go public?

    Opus Genetics, Inc.'s initial public offering (IPO) was on January 19, 2015

    Is Opus Genetics, Inc. in the S&P 500?

    No, Opus Genetics, Inc. is not included in the S&P 500 index

    Is Opus Genetics, Inc. in the NASDAQ 100?

    No, Opus Genetics, Inc. is not included in the NASDAQ 100 index

    Is Opus Genetics, Inc. in the Dow Jones?

    No, Opus Genetics, Inc. is not included in the Dow Jones index

    When was Opus Genetics, Inc.'s last earnings report?

    Opus Genetics, Inc.'s most recent earnings report was on May 8, 2025

    When does Opus Genetics, Inc. report earnings?

    The date for Opus Genetics, Inc.'s next earnings report has not been announced yet
    On this page